Related Experiment Videos
Antitumor agents. 16. Steroidal alpha-methylene-gamma-lactones
Journal of Medicinal Chemistry
|August 1, 1975
Summary
Novel steroidal lactones show significant antitumor activity. These potential alkylating agents demonstrated cytotoxicity against human cancer cells and inhibited tumor growth in vivo.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Pharmacology
Background:
- Steroidal compounds are explored for antitumor properties.
- Alpha-methylene-gamma-lactones are a class of compounds with potential biological activity.
- Development of novel steroid alkylating antitumor agents is an ongoing area of research.
Purpose of the Study:
- To synthesize novel steroidal alpha-methylene-gamma-lactones and derivatives.
- To evaluate the in vitro cytotoxicity of these compounds against human epidermoid carcinoma cells.
- To assess the in vivo antitumor activity of these novel steroidal agents.
Main Methods:
- Synthesis via Reformatsky-type reaction of ethyl-alpha-(bromomethyl)acrylate and steroidal ketones.
- In vitro cytotoxicity assays using H.Ep.-2 (human epidermoid carcinoma of the larynx) cell lines.
- In vivo tumor assays in rodent models (Walker 256 carcinosarcoma, L1210 lymphoid leukemia, Ehrlich ascites carcinoma).
Main Results:
- Synthesized novel steroidal alpha-methylene-gamma-lactones and related derivatives.
- Demonstrated significant in vitro cytotoxicity against H.Ep.-2 cells.
- Observed at least sixfold improvement in cytotoxicity with lipophilic steroidal character.
- Showed in vivo activity against Walker 256 carcinosarcoma in rats.
- Found inactive against L1210 lymphoid leukemia and Ehrlich ascites carcinoma in mice.
- Identified alpha-methylene-beta,beta-dicarbethoxy-gamma-butyrolactone as a significant inhibitor of Ehrlich ascites tumor growth.
Conclusions:
- Novel steroidal alpha-methylene-gamma-lactones are effective potential steroid alkylating antitumor agents.
- Lipophilic steroidal character enhances cytotoxicity.
- These compounds exhibit selective in vivo antitumor activity in specific cancer models.